With expert opinions being silenced by a higher power, a House
subcommittee will likely require the FDA to issue strong "black
box" warnings on antidepressant drugs for children. This action
is due to the link between the antidepressant drugs and increased
suicidal behavior in some children taking the drugs.
A FDA member suggested that patients taking antidepressant prescriptions
should receive information pamphlets and stronger warnings. These
warnings will ensure that each patient is educated on how to balance
the risk of suicide with the benefits of treating depression.
It seems that government epidemiologists have also felt the wrath
of the FDA's urge to keep things under the radar. Some have been
asked by their superiors to soften their recommendations of discouraging
most antidepressant drugs because of increased suicidal behavior
linked to drug use.
A member of the FDA's Division of Drug and Risk Evaluation claimed
managers asked him to refrain from down-talking the use of all antidepressants
and instead inform patients to proceed in using such drugs, but
"with caution." Research has shown Prozac to be the only
drug approved to treat children with the least risk for depressed
children.
Other information retained:
- Paxil and seven other antidepressants caused children to suffer
from increased suicidal behavior more so than children taking
sugar pills.
- Out of every 100 children taking antidepressants in controlled
clinical trials an additional tow to three children experienced
increased suicidal tendencies.
Denying statements, the FDA stated they did not ask one of their
experts to change their review on the drugs, but merely made some
suggestions.
Some members of the House subcommittee charged the FDA with a pattern
of deception, noting no agency charged with protecting the public's
heath should act in any way as to compromise the public's safety.
Yahoo
News September 23, 2004
|